|
|
||||||||
1 The 2nd Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama 930-0194, and 2 Research Laboratories, Daiichi Radioisotope Laboratories, Chiba 289-1592, Japan
| |
ABSTRACT |
|---|
|
|
|---|
We examined cardiac neuronal function and
-receptor
with a dual-tracer method of
[131I]meta-iodobenzylguanidine (MIBG) and
[125I]iodocyanopindolol (ICYP) in rat heart
failure after myocardial infarction (MI). In rats with MI, left
ventricular (LV) systolic function decreased, and LV dimension and
right ventricular (RV) mass increased gradually. MIBG accumulations of
the noninfarcted LV (remote region) and RV decreased by 15% at 1 wk
compared with sham-operated rats, and these accumulations were restored
by 71% and 56%, respectively, at 24 wk compared with
age-matched sham rats despite sustained depletion of myocardial
norepinephrine contents in these regions. ICYP accumulation of the
remote region and of the RV did not decrease at any stages. Myocardial
MIBG distribution was heterogeneous at 1 wk when it was lower in the peri-infarcted region than in the remote region, associated with reduced ICYP accumulation in the peri-infarcted region. The
heterogeneous distribution of both isotopes disappeared at 12 wk. Thus
cardiac sympathetic neuronal alteration was coupled with downregulation of
-receptors in rat heart failure after MI. The abnormal adrenergic signaling occurred heterogeneously in terms of ventricular distribution and time course after MI.
autonomic nervous system;
-receptors; radioisotopes; dual-tracer
method
| |
INTRODUCTION |
|---|
|
|
|---|
AN INCREASED SYMPATHETIC NERVE activity after
myocardial infarction (MI) may contribute to the progression of cardiac
remodeling and heart failure and, consequently, increased mortality.
Many studies have demonstrated that plasma catecholamine concentrations increase (17, 30) and norepinephrine (NE) contents of the noninfarcted
myocardium are depleted after MI (16, 31, 45), suggesting an increased
sympathetic nerve activity. However, an impaired cardiac sympathetic
neuronal function seen in heart failure may also affect cardiac
adrenergic signaling, because synaptic NE levels depend on circulating
NE, the amount of neuronal release, and subsequent inactivation by
neuronal uptake. The increased sympathetic activity and/or impaired
neuronal function after MI would promote an impairment of cardiac
response to
-adrenergic stimulation (42) and also a decrease in
-receptor density (4, 7, 15). Thus alterations of cardiac adrenergic
signaling might contribute to the progression of heart failure.
However, there is little information of a relationship between cardiac neuronal function and
-receptors during the progression of heart failure after MI.
Recently, we established a dual-tracer method to assess sympathetic
neuronal function with [131I]meta- iodobenzylguanidine
(MIBG), an analog of NE, and
-receptors with
[125I]iodocyanopindolol (ICYP) in rats (24).
Using this method, we designed the present study to elucidate serial
changes in cardiac sympathetic neuronal function and
-receptor
density from an early stage after MI to a chronic stage with cardiac
remodeling in rats.
| |
METHODS |
|---|
|
|
|---|
The present study was undertaken in accordance with the guideline for animal experiment at Toyama Medical and Pharmaceutical University.
Experimental animals. Male Wistar rats weighing 300-350 g were used for induction of MI. MI was produced by ligating the left coronary artery while the rats were under ether anesthesia as described by Pfeffer et al. (26). Briefly, a left thoracotomy was performed to exteriorize the heart rapidly. The left coronary artery was ligated ~2 mm from its origin with a suture of 6-0 silk. With this method, the 24-h survival rate was 57% in the infarcted rats. Control rats were sham operated by using a similar procedure without coronary ligation. All rats were fed standard rat chow and given water ad libitum throughout the experiment. Rats were divided into three groups. The first group was used for hemodynamic study and for measurements of plasma and cardiac tissue catecholamine levels. The second group was used for the assessment of myocardial MIBG and ICYP accumulation. The third group was used for cardiac autoradiography to evaluate ventricular distribution of MIBG and ICYP. Data were collected at 1, 4, 12, and 24 wk after the operation in the first two groups and at 1 and 12 wk in the third group.
MI size was determined using a technique described by Chien et al. (3). Briefly, the right ventricle (RV) and left ventricle (LV) including the interventricular septum (IVS) were dissected, separated, and weighed. Incisions were made in the LV so that the LV tissue could be pressed flat. The circumference of entire flat LV and the visualized infarcted area, as judged from both epicardial and endocardial sides, were outlined on a clear plastic sheet. The difference in weight between the two marked areas on the sheet was used to determine the size of MI and was expressed as a percentage of LV surface area. Rats with an infarcted size >30% of LV was used for data analysis in this study.
Hemodynamic study and measurement of catecholamines. Transthoracic echocardiography was performed with the rat under ether anesthesia 1 day before the hemodynamic study with a commercially available echocardiographic system equipped with a 7.5-MHz transducer (SSH140A, Toshiba, Japan). A two-dimensional, short-axis view of the LV was obtained at the level of the papillary muscle, and the two-dimensional-targeted M-mode tracings were recorded through the anterior and posterior LV walls. End-diastolic and end-systolic LV internal dimensions were determined by the American Society for Echocardiology leading-edge methods from at least three consecutive cardiac cycles on the M-mode tracings.
The hemodynamic study was performed on ether-anesthetized rats. A 2-Fr. micromanometer-tipped catheter (Millar Instruments) was inserted into the right carotid artery and advanced into the LV to determine LV pressure. With the rat anesthetized lightly and breathing spontaneously, LV pressure and electrocardiograms were recorded on a multichannel thermal recorder (WR3151, Nihon Kohden, Tokyo, Japan). These signals were digitized on-line at 2-ms intervals and analyzed with a signal-processing computer system (7T-18, NEC San-Ei, Tokyo, Japan).
After the hemodynamic study, blood was drawn from the carotid artery
for an analysis of plasma catecholamines. Pentobarbital sodium (70 mg/kg) was then injected intraperitoneally. The chest was opened and
the heart was quickly removed. After the RV and LV were dissected,
rinsed in ice-cold saline, and weighed, infarcted size was determined
by the method described above. The remaining noninfarcted LV (remote
region) was cut and prepared free of both scar tissue and
peri-infarcted regions for measurement of tissue catecholamines. Plasma
and noninfarcted LV and RV tissue samples were stored at
80°C for later analyses. Catecholamines were determined by
an automated high-performance liquid chromatography as described previously (24).
MIBG and ICYP accumulation. The method for determinating MIBG and ICYP accumulation was reported previously (24). Briefly, a 20-µCi of MIBG was injected via the external jugular vein with the rat under anesthesia with pentobarbital sodium (30 mg/kg ip). Two hours later a 10-µCi of ICYP was given intravenously. Rats were killed at 1 h after the ICYP injection. The heart was removed from the chest, and LV and RV were dissected. After the determination of infarct size, noninfarcted LV (remote region) and RV counts of MIBG and ICYP were determined with a gamma counter (ARC 2000, Aroka, Japan). The ICYP counts were determined 60 days later following the decay of MIBG. In our previous study (24), a cross talk from ICYP to MIBG window was <3%, and therefore we neglect the cross talk between 125I and 131I. To normalize MIBG and ICYP accumulation for differences in animal weight, tissue accumulations of MIBG and ICYP were expressed in percent kilogram dose per gram of tissue wet weight (%kg dose/g).
Dual-tracer autoradiography. Dual-tracer autoradiography was
performed as described previously (24). Briefly, rats were injected
intravenously with 50 µCi of MIBG and 2 h later with an injection of
5 µCi of ICYP. The heart was removed 1 h after the second injection.
Serial 20-µm thick transverse sections of the heart were obtained
after freezing the specimens. The first autoradiographic exposure on an
imaging plate (BAS-UR, Fuji, Japan) was carried out for 6 h to reveal
MIBG distribution. The second exposure was initiated 60 days later
following the decay of MIBG activity and required 21 days for adequate
image quality. A myocardial section at a level of papillary muscle was
used for quantification of myocardial distribution of MIBG and ICYP. As
shown in Fig. 1, four regions of interest
(ROIs) were determined, i.e., the infarcted region, the peri-infarcted
region (noninfarcted region adjacent to the infarcted region), the
remote region (noninfarcted interventricular septum), and RV. After the
autoradiographic study, the same myocardial section was stained with
hematoxylin-eosin, and the infarcted and noninfarcted regions were
confirmed histologically. The similar determination of ROIs was
performed in sham-operated rats. These sections were quantified using a
bioimaging analyzer (BAS3000, Fuji, Japan), as described previously
(24). Ventricular distribution was expressed as a relative accumulation
of each region to RV.
|
Statistical analysis. Results are expressed as means ± SD. Comparison of variables was done with two-way ANOVA with time (week) and group (MI vs. sham) as the main effects. Where appropriate, comparisons to determine the significance of changes within the same group over time and between groups at each time interval were performed with the Bonferroni test for multiple comparisons (43). One-way ANOVA with the Bonferroni test was used for comparison of the autoradiographic data at each time point. A P value < 0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Hemodynamics and LV geometry. Infarct size ranged from 31 to
50% of LV and was similar among groups with different post-MI weeks
(Table 1). There was no significant
difference in body weight between MI and age-matched, sham-operated
rats. RV mass indexed for body weight (RV/BW) was significantly greater
in MI rats than in sham-operated rats at each age.
|
Hemodynamic data are shown in Table 2. LV
systolic pressure was lower in MI rats than in sham-operated rats. LV
end-diastolic pressure was not different between MI and sham-operated
rats at 1 wk, and thereafter it elevated significantly in MI rats. A
maximum value of the rate of change in LV pressure
(dP/dtmax) and a minimum value of dP/dt
(dP/dtmin) decreased significantly in MI rats
throughout the study period.
|
LV end-diastolic dimension was larger in MI rats than in sham-operated rats and gradually increased during the study period in MI rats (Table 2). LV fractional shortenings decreased significantly in MI rats at each age.
Myocardial NE contents. Plasma NE levels tended to be higher in
MI rats compared with the levels in the sham-operated rats, but the
differences did not reach statistical significance (1.1 ± 0.8 vs. 0.6 ± 0.1 ng/ml at 1 wk, 0.8 ± 0.3 vs. 0.6 ± 0.2 ng/ml at 4 wk, 1.5 ± 0.4 vs. 0.9 ± 0.2 ng/ml at 12 wk, and 1.1 ± 0.4 vs. 0.8 ± 0.4 ng/ml at 24 wk). Markedly decreased myocardial NE contents in
the noninfarcted LV (remote region) and RV in MI rats at the early
stage after MI continued to the chronic stage (Fig. 2).
|
Cardiac MIBG accumulation and distribution. Figure
3 shows MIBG accumulation of the
noninfarcted LV (remote region) and RV in MI and sham-operated rats. LV
infarct size was similar among four groups with different post-MI
stages (38 ± 7% at 1 wk, 32 ± 3% at 4 wk, 36 ± 7% at
12 wk, and 35 ± 5% at 24 wk). In MI rats, the decreases in MIBG
accumulation were prominent at 1 wk (15% of sham-operated rats) in
both the LV and RV. The accumulation was gradually restored at chronic
stages and was 71% (LV) and 56% (RV) in the sham-operated rats at 24 wk. The reduced differences in MIBG accumulation between MI and
sham-operated rats at chronic stages were partially due to gradual
decreases in the MIBG accumulation with age in sham-operated rats (Fig.
3).
|
The MIBG distribution of LV was homogeneous in sham-operated rats but
was heterogeneous in MI rats (Fig. 4). A
quantitative analysis of MIBG distribution showed that the accumulation
of the peri-infarcted region was significantly lower than that of the
remote region at 1 wk but was restored at 12 wk (Fig.
5). In sham-operated rats, the MIBG
accumulation of the LV including the ventricular septum was homogeneous
at 1 and 12 wk.
|
|
Cardiac ICYP accumulation and distribution. ICYP accumulation
of the noninfarcted LV (remote region) and RV was not significantly different between MI and sham-operated rats at all stages, although ICYP accumulation of RV tended to be lower in rats with MI (Fig. 6). Ventricular distribution of ICYP in MI
rats showed that the accumulation was significantly lower in the
peri-infarcted region than in the LV remote region at 1 wk and became
homogeneous except the infarcted region at 12 wk (Figs.
7 and 8). The
ICYP accumulation was homogeneous in the sham-operated rats.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The major findings of the present study are as follows. First, a marked
decrease in MIBG accumulation of the LV remote region and RV occurred
at the early stage after MI and was gradually restored at the chronic
stage despite a sustained depletion of myocardial NE and a gradual
ventricular enlargement. Second, a heterogeneous MIBG distribution at
the early stage, i.e., lower accumulation in the peri-infarcted region,
became homogeneous except for the infarcted region at the chronic
stage. Third, markedly reduced MIBG accumulation in the peri-infarcted
region in the early stage was associated with reduced ICYP
accumulation, a phenomenon of downregulation of
-receptors. MIBG and
ICYP accumulations were, however, restored at the chronic stage. Thus a
cardiac sympathetic neuronal function was coupled with
-receptor
density, and the neuronal alteration and downregulation of
-receptors occurred heterogeneously in terms of ventricular
distribution and the time course after MI.
Heart failure after MI in rats was characterized by reduced LV systolic function, increased LV filling pressure and volume, and increased RV mass (5, 26), all observed in the present study. Despite reduced LV systolic function at the early stage, there was no increase in ventricular filling pressure, a consistent finding with the previous report (10). At the chronic stage after MI, markedly increased LV end-diastolic pressure and LV systolic dysfunction were associated with gradual increases in LV dimension and RV mass in the present study, suggesting a progressive ventricular remodeling in both ventricles after MI.
A decrease in myocardial NE is commonly observed in heart failure (2, 28). Depletion of myocardial NE in the noninfarcted LV and RV was reported at both acute and chronic stages after MI in experimental animals (6, 12, 31, 45). This depletion could be attributed to an increase in cardiac sympathetic discharge and NE release from the nerve terminal in heart failure (19, 35). A magnitude of increased sympathetic activation after MI depends on the extent of cardiac damage and hemodynamic consequences (17, 30). In the present study, depleted cardiac NE was seen at the early stage and was sustained until the chronic stage, at which a reduction of stroke volume due to MI could be compensated by an enlargement of ventricular volume. The present results suggest that increased cardiac sympathetic activity after MI might be sustained throughout the study periods and contribute to further ventricular remodeling (25), in association with increased wall stress due to an enlargement of ventricular volume and increased filling pressure.
MIBG is an analog of NE and shares neuronal transport and storage mechanisms with NE (23, 34). Decreased cardiac MIBG uptake has been reported in both clinical (9) and experimental heart failure (29, 32). Several mechanisms for decreased MIBG accumulation in heart failure could be proposed. Among them are increased neuronal release of MIBG by sympathetic activation, impaired cardiac neuronal uptake of MIBG, and decreased adrenergic neuron density.
Nonneuronal MIBG accumulation has been reported to reach 30-50% of the total cardiac accumulation in rats, hamsters, and dogs studied 3-4 h after MIBG injection (23, 29, 40). A magnitude of nonneuronal accumulation was assessed using neuronal uptake-1 blocker in most studies. However, Sisson et al. (34) reported 69% or more neuronal uptake in rats, in which 6-hydroxydopamine was used to impair function of the nerve terminals, although the selective uptake-1 blocker desmethlimipramine reduced MIBG accumulation only to 50% of the control. Cardiac MIBG accumulation is also influenced by the specific activity, and it markedly decreases following a high MIBG dose. In the present study, MIBG with high specific activity (65 Ci/mmol) was used at a low dose. A recent rat experiment, using MIBG with a high specific activity, revealed an accumulation of 80-90% of MIBG in cardiac sympathetic neurons 3 h after injection and a storage of 70-80% of MIBG in adrenal vesicles (M. Inoue, unpublished data). In the present study, it is unlikely that reduced MIBG accumulation in the LV remote region and RV would be due to sympathetic denervation with the operative procedure because the accumulation did not decrease in the sham-operated rats. Therefore, cardiac MIBG accumulation in the present study can be regarded as a reflection of cardiac sympathetic neuronal function, although some amount of MIBG injected would be taken up by nonneuronal tissue in the heart.
In our previous study, cardiac washout rate of MIBG, an index of sympathetic activity, increased significantly in noninfarcted myocardium after MI compared with sham-operated rats (unpublished data). An acute hemodynamic deterioration and subsequent activation of cardiac sympathetic nerve and/or impaired cardiac neuronal uptake function would lead to a decrease in cardiac MIBG accumulation at the early stage after MI. In the chronic stage (12-24 wk), however, an improvement of cardiac MIBG accumulation was not associated with a restoration of cardiac NE. Along with hemodynamic stabilization, cardiac neuronal uptake function might be improved and cardiac MIBG accumulation recovered gradually. The sustained decreases in cardiac NE at the chronic stage may be due to an increased sympathetic activity and insufficient NE synthesis in the nerve (27). The discrepancy between cardiac MIBG accumulation and NE contents was observed in earlier studies (24, 36).
In patients with MI, the area of reduced cardiac MIBG uptake is often greater than that of a myocardial perfusion defect with thallium-201 chloride (18, 37). In the present study of cardiac autoradiography, the MIBG accumulation was significantly less in the peri-infarcted region than in the remote region at the early stage, although the accumulation decreased even in the remote region compared with the sham-operated rats. The reduced accumulation in the peri-infarcted region was restored at the chronic stage, a consistent finding with the previous observations (8, 20).
Sisson et al. (33) reported that an intravenous injection of ICYP bound
predominantly to
-receptors and nonspecific binding was 10-20%
of total bindings. In our previous study (24), the amount of cardiac
ICYP accumulation was comparable to the maximal binding capacity of
-receptors assessed by radioligand receptor assay in a membrane
preparation in rats. Because a 20-µm transverse section of heart for
autoradiography was fixed on the slide glass, a 60-day delay could not
affect ICYP densities in each region of the heart. Therefore, we
consider that the present method would reasonably reflect changes in
distribution and density of
-receptors in a heart.
In the present study, there were no significant changes in ICYP
accumulation in both the LV remote region and RV after MI, which is
consistent with the earlier study (1) in which membrane preparation was
used for measurement of
-receptor density. In contrast,
a significant reduction of
-receptor density was reported in the
noninfarcted myocardium (31, 44). These differences may be attributed
to the MI size and the period examined after MI.
In the present autoradiographic study, markedly reduced MIBG
accumulation in the peri-infarcted region was accompanied with reduction in ICYP accumulation at the early stage. Similar findings of
decreased
-receptor density in the peri-infarcted region were observed in previous studies (13, 38). A peri-infarcted myocardium, in
which MIBG accumulation is reduced but coronary flow is preserved, is
considered to be "denervated but viable" (18, 37). A direct influence of ischemia by the coronary occlusion might
contribute to the reduced MIBG and ICYP accumulations in the
peri-infarcted region. Acute myocardial ischemia has been
reported to lead to an increase in
-receptor density (21). A cardiac
sympathetic denervation would be associated with an increased (41) or
unchanged density of
-receptors (11). Delehanty et al. (4) reported that synaptic NE levels were inversely related with
-receptor densities in heart failure. Therefore, our data suggest
that reduction of MIBG accumulation in the peri-infarcted region at the
early stage after MI might not be induced by the sympathetic
denervation. An increased synaptic NE due to increased NE releases
and/or impairs its reuptake, which might induce the downregulation of
-receptors in the peri-infarcted region at the early
stage, a consistent finding with our previous observations in
hypertensive heart failure rats (24).
The relative MIBG accumulation of the remote region (IVS) to RV was lower at 12 wk than at 1 wk in MI rats (Fig. 5). A similar finding was observed in ICYP accumulation (Fig. 8). However, the "absolute accumulation (%kg dose/g)" of both isotopes, especially MIBG accumulation, in the remote region increased from week 1 to week 12 (Figs. 3 and 6). Therefore, it is unlikely that the homogenized distribution of isotopes in the remote and peri-infarcted regions at 12 wk may be due to the reduced accumulation in the remote region.
Some methodological limitations deserve comments in interpreting the present results. First, myocardial blood flow that would influence MIBG and ICYP accumulation was not evaluated in the present study. However, markedly decreased MIBG accumulation was found even in the remote region of LV and RV. Recently, Kramer et al. (14) reported that MIBG accumulation was reduced in the peri-infarcted region relative to the remote region, in which blood flow was preserved. Some amount of MIBG injected may be taken up by nonneuronal tissue in the heart. Takatsu et al. (39) reported that the reduced MIBG accumulation in the infarcted region after coronary occlusion followed by the reperfusion might result from a deficit in nonneuronal accumulation. The influence of the nonneuronal accumulation in the present results was not evaluated, although the present study was performed without the reperfusion after the coronary occlusion. The influence of regional blood flow and nonneuronal MIBG accumulation requires further study. Second, we did not determine the infarct size with the standard histological method but determined with macroscopic boundary of scar as described by Chien et al. (3). This method may underestimate the infarct size compared with the histological method (6). Because rats with MI were compared with rats without MI, this underestimation might not seriously affect the present results. Finally, blood sampling for NE measurement was performed with the animals under anesthesia, which could affect the level of plasma NE. In the study by Musch and Zelis (22), the plasma NE in conscious unrestrained rats without MI is lower than that found in the present study. The influence of anesthesia might account for the lack of the significant differences in plasma NE between sham-operated and MI rats in the present study.
Although limited for these reasons, the present method of dual tracers
with MIBG and ICYP is useful for an in vivo evaluation of changes in
the cardiac adrenergic signaling after MI. The present results suggest
that the increased sympathetic activity accompanied with the neuronal
dysfunction in the early stage after MI might cause the downregulation
of
-receptors. In the chronic stage after hemodynamic stabilization,
an increased wall stress as well as the sustained neural activity might
contribute to further ventricular enlargement despite a restoration of
the neuronal function. Cardiac sympathetic alteration and
downregulation of
-receptors occur heterogeneously in terms of
ventricular distribution and periods after MI.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Science, and Culture (6670701).
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: T. Nozawa, The 2nd Dept. of Internal Medicine, Toyama Medical & Pharmaceutical Univ., 2630 Sugitani, Toyama 930-0194, Japan (E-mail: tnozawa{at}ms.toyama-mpu.ac.jp).
Received 9 April 1999; accepted in final form 19 October 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Cherng, WJ,
Liang C-s.,
and
Hood WB, Jr.
Effects of metoprolol on left ventricular function in rats with myocardial infarction.
Am J Physiol Heart Circ Physiol
266:
H787-H794,
1994
2.
Chidsey, CA,
Braunwald E,
and
Morrow AG.
Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure.
Am J Med
39:
442-451,
1965[Web of Science][Medline].
3.
Chien, YW,
Barbee RW,
MacPhee AA,
Frohlich ED,
and
Trippodo NC.
Increased ANF secretion after volume expansion is preserved in rats with heart failure.
Am J Physiol Regulatory Integrative Comp Physiol
254:
R185-R191,
1988
4.
Delehanty, JM,
Himura Y,
Elam H,
Hood WB, Jr,
and
Liang C-s
-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content.
Am J Physiol Heart Circ Physiol
266:
H930-H935,
1994
5.
Fletcher, PJ,
Pfeffer JM,
Pfeffer MA,
and
Braunwald E.
Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function.
Circ Res
49:
618-626,
1981
6.
Fraccarollo, D,
Hu K,
Galuppo P,
Gaudron P,
and
Ertl G.
Chronic endothelin receptor blockade attenuates progressive ventricular dilatation and improves cardiac function in rats with myocardial infarction. Possible involvement of myocardial endothelin system in ventricular remodeling.
Circulation
96:
3963-3973,
1997
7.
Gilbert, EM,
Sandoval A,
Larrabee P,
Renlund DG,
O'Connell JB,
and
Bristow MR.
Lisinopril lowers cardiac adrenergic drive and increases
-receptor density in the failing human heart.
Circulation
88:
472-480,
1993
8.
Hartikainen, J,
Kuikka J,
Mäntysaari M,
Länsimies E,
and
Pyörälä K.
Sympathetic reinnervation after acute myocardial infarction.
Am J Cardiol
77:
5-9,
1996[Web of Science][Medline].
9.
Henderson, EB,
Kahn JK,
Corbett JR,
Jansen DE,
Pippin JJ,
Kulkarni P,
Ugolini V,
Akers MS,
Hansen C,
Buja LM,
Parkey RW,
and
Willerson JT.
Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.
Circulation
78:
1192-1199,
1988
10.
Hill, MF,
and
Singal PK.
Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction.
Circulation
96:
2414-2420,
1997
11.
Kammerling, JJ,
Green FJ,
Watanabe AM,
Inoue H,
Barber MJ,
Henry DP,
and
Zipes DP.
Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction.
Circulation
76:
383-393,
1987
12.
Kozlovskis, PL,
Fieber LA,
Bassett AL,
Cameron JS,
Kimura S,
and
Myerburg RJ.
Regional reduction in ventricular norepinephrine after healing of experimental myocardial infarction in cats.
J Mol Cell Cardiol
18:
413-422,
1986[Web of Science][Medline].
13.
Kozlovskis, PL,
Smets MJD,
Duncan RC,
Bailey BK,
Bassett AL,
and
Myerburg RJ.
Regional
-adrenergic receptors and adenylate cyclase activity after healing of myocardial infarction in cats.
J Mol Cell Cardiol
22:
311-322,
1990[Web of Science][Medline].
14.
Kramer, CM,
Nicol PD,
Rogers WJ,
Suzuki MM,
Shaffer A,
Theobald TM,
and
Reichek N.
Reduced sympathetic innervation underlies adjacent noninfarcted region dysfunction during left ventricular remodeling.
J Am Coll Cardiol
30:
1079-1085,
1997[Abstract].
15.
Liang, C-s.,
Fan THM,
Sullebarger JT,
and
Sakamoto S.
Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to
-adrenoceptor downregulation.
J Clin Invest
84:
1267-1275,
1989.
16.
Mathes, P,
Cowan C,
and
Gudbjarnason S.
Storage and metabolism of norepinephrine after experimental myocardial infarction.
Am J Physiol
220:
27-32,
1971.
17.
McAlpine, HM,
Morton JJ,
Leckie B,
Rumley A,
Gillen G,
and
Dargie HJ.
Neuroendocrine activation after acute myocardial infarction.
Br Heart J
60:
117-124,
1988
18.
McGhie, AI,
Corbett JR,
Akers MS,
Kulkarni P,
Sills MN,
Kremers M,
Buja LM,
Durant-Reville M,
Parkey RW,
and
Willerson JT.
Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction.
Am J Cardiol
67:
236-242,
1991[Web of Science][Medline].
19.
Meredith, IT,
Eisenhofer G,
Lambert GW,
Dewar EM,
Jennings GL,
and
Esler MD.
Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
Circulation
88:
136-145,
1993
20.
Minardo, JD,
Tuli MM,
Mock BH,
Weiner RE,
Pride HP,
Wellman HN,
and
Zipes DP.
Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application.
Circulation
78:
1008-1019,
1988
21.
Mukherjee, A,
Bush LR,
McCoy KE,
Duke RJ,
Hagler H,
Buja LM,
and
Willerson JT.
Relationship between
-adrenergic receptor numbers and physiological responses during experimental canine myocardial ischemia.
Circ Res
50:
735-741,
1982
22.
Musch, TI,
and
Zelis R.
Norepinephrine response to exercise of rats with a chronic myocardial infarction.
Med Sci Sports Exerc
23:
569-577,
1991[Web of Science][Medline].
23.
Nakajo, M,
Shimabukuro K,
Yoshimura H,
Yonekura R,
Nakabeppu Y,
Tanoue P,
and
Shinohara S.
Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart.
J Nucl Med
27:
84-89,
1986
24.
Nozawa, T,
Igawa A,
Yoshida N,
Maeda M,
Inoue M,
Yamamura Y,
Asanoi H,
and
Inoue H.
Dual-tracer assessment of coupling between cardiac sympathetic neuronal function and downregulation of
-receptors during development of hypertensive heart failure of rats.
Circulation
97:
2359-2367,
1998
25.
Packer, M.
The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.
J Am Coll Cardiol
20:
248-254,
1992[Abstract].
26.
Pfeffer, MA,
Pfeffer JM,
Fishbein MC,
Fletcher PJ,
Spadaro J,
Kloner RA,
and
Braunwald E.
Myocardial infarct size and ventricular function in rats.
Circ Res
44:
503-512,
1979
27.
Pool, PE,
Covell JW,
Levitt M,
Gibb J,
and
Braunwald E.
Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure: its role in the depletion of cardiac norepinephrine stores.
Circ Res
20:
349-353,
1967
28.
Port, JD,
Gilbert EM,
Larrabee P,
Mealey P,
Volkman K,
Ginsburg R,
Hershberger RE,
Murray J,
and
Bristow MR.
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
Circulation
81:
929-938,
1990
29.
Rabinovitch, MA,
Rose CP,
Rouleau JL,
Chartrand C,
Wieland DM,
Lepanto L,
Legault F,
Suissa S,
Rosenthall L,
and
Burgess JH.
Metaiodobenzylguanidine [131I] scintigraphy detects impaired myocardial sympathetic neuronal transport function of canine mechanical-overload heart failure.
Circ Res
61:
797-804,
1987
30.
Rouleau, JL,
de Champlain J,
Klein M,
Bichet D,
Moyé L,
Packer M,
Dagenais GR,
Sussex B,
Arnold JM,
Sestier F,
Parker JO,
McEwan P,
Bernstein V,
Cuddy TE,
Lamas G,
Gottlieb SS,
McCans J,
Nadeau C,
Delage F,
Hamm P,
and
Pfeffer MA.
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
J Am Coll Cardiol
22:
390-398,
1993[Abstract].
31.
Sanbe, A,
and
Takeo S.
Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac
-adrenoceptor responses in rats with chronic heart failure.
Circulation
92:
2666-2675,
1995
32.
Simmons, WW,
Freeman MR,
Grima EA,
Hsia TW,
and
Armstrong PW.
Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.
Circulation
89:
2843-2851,
1994
33.
Sisson, JC,
Wieland DM,
Koeppe RA,
Normolle D,
Frey KA,
Bolgos G,
Johnson J,
Van Dort ME,
and
Gildersleeve DL.
Scintigraphic portrayal of
receptors in the heart.
J Nucl Med
32:
1399-1407,
1991
34.
Sisson, JC,
Wieland DM,
Sherman P,
Mangner TJ,
Tobes MC,
and
Jacques S, Jr.
Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function.
J Nucl Med
28:
1620-1624,
1987
35.
Sole, MJ,
Lo CM,
Laird CW,
Sonnenblick EH,
and
Wurtman RJ.
Norepinephrine turnover in the heart and spleen of the cardiomyopathic Syrian hamster.
Circ Res
37:
855-862,
1975
36.
Somsen, GA,
Dubois EA,
Brandsma K,
de Jong J,
van der Wouw PA,
Batink HD,
van Royen EA,
Lie KI,
and
van Zwieten PA.
Cardiac sympathetic neuronal function in left ventricular volume and pressure overload.
Cardiovasc Res
31:
132-138,
1996[Web of Science][Medline].
37.
Stanton, MS,
Tuli MM,
Radtke NL,
Heger JJ,
Miles WM,
Mock BH,
Burt RW,
Wellman HN,
and
Zipes DP.
Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine.
J Am Coll Cardiol
14:
1519-1526,
1989[Abstract].
38.
Steinberg, SF,
Zhang HL,
Pak E,
Pagnotta G,
and
Boyden PA.
Characteristics of the
-adrenergic receptor complex in the epicardial border zone of the 5-day infarcted canine heart.
Circulation
91:
2824-2833,
1995
39.
Takatsu, H,
Duncker CM,
Arai M,
and
Becker LC.
Cardiac sympathetic nerve function assessed by 131I-metabenzylguanidine after ischemia and reperfusion in anesthetized dogs.
J Nucl Cardiol
4:
35-41,
1997[Medline].
40.
Takatsu, H,
Uno Y,
and
Fujiwara H.
Modulation of left ventricular iodine-125-MIBG accumulation in cardiomyopathic syrian hamsters using the renin-angiotensin system.
J Nucl Med
36:
1055-1061,
1995
41.
Vatner, DE,
Lavallee M,
Amano J,
Finizola A,
Homcy CJ,
and
Vatner SF.
Mechanisms of supersensitivity to sympathomimetic amines in the chronically denervated heart of the conscious dog.
Circ Res
57:
55-64,
1985
42.
Vatner, DE,
Vatner SF,
Nejima J,
Uemura N,
Susanni EE,
Hintze TH,
and
Homcy CJ.
Chronic norepinephrine elicits desensitization by uncoupling the
-receptor.
J Clin Invest
84:
1741-1748,
1989.
43.
Wallenstein, S,
Zucker CL,
and
Fleiss JL.
Some statistical methods useful in circulation research.
Circ Res
47:
1-9,
1980
44.
Warner, AL,
Bellah KL,
Raya TE,
Roeske WR,
and
Goldman S.
Effects of
-adrenergic blockade on papillary muscle function and the
-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction.
Circulation
86:
1584-1595,
1992
45.
Zelis, R,
Clemson B,
Baily R,
and
Davis D.
Regulation of tissue noradrenaline in the rat myocardial infarction model of chronic heart failure.
Cardiovasc Res
26:
933-938,
1992
This article has been cited by other articles:
![]() |
N. Fujii, T. Nozawa, A. Igawa, B.-i. Kato, N. Igarashi, M. Nonomura, H. Asanoi, S. Tazawa, M. Inoue, and H. Inoue Saturated glucose uptake capacity and impaired fatty acid oxidation in hypertensive hearts before development of heart failure Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H760 - H766. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuda, E. Gao, L. Evangelisti, D. Markova, X. Ma, and M.-L. Chu Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes Cardiovasc Res, October 1, 2003; 59(4): 926 - 933. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |